Patents by Inventor Xiaoting YANG

Xiaoting YANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12103869
    Abstract: The application belongs to the technical field of water treatment, and relates to a biofilm electrochemical reactor for simultaneously removing nitrate nitrogen and trace organic matters in water.
    Type: Grant
    Filed: January 19, 2020
    Date of Patent: October 1, 2024
    Inventors: Jincheng Li, Wenxiang Xia, Yanyan Wang, Xiaoting Yang, Baoxiu Zhao, Jie Liu, Xiaoli Zhao
  • Publication number: 20220033286
    Abstract: The application belongs to the technical field of water treatment, and relates to a biofilm electrochemical reactor for simultaneously removing nitrate nitrogen and trace organic matters in water.
    Type: Application
    Filed: January 19, 2020
    Publication date: February 3, 2022
    Inventors: Jincheng LI, Wenxiang XIA, Yanyan WANG, Xiaoting YANG, Baoxiu ZHAO, Jie LIU, Xiaoli ZHAO
  • Publication number: 20210145802
    Abstract: A thiazolidinedione or rhodanine compound or a pharmaceutically acceptable salt, tautomer, solvate, hydrate, prodrug, derivative, stereoisomer, analog or isotopically labelled derivative thereof, for use in the treatment and/or prevention of an ophthalmological condition, wherein said compound is not Pioglitazone, Rosiglitazone, Rivoglitazone, Balaglitazone or Mitoglitazone.
    Type: Application
    Filed: April 4, 2019
    Publication date: May 20, 2021
    Inventors: Johnny HABCHI, Xiaoting YANG, Kerry JENKINS, Michele PERNI, Sunehera SARWAT, Joseph MENZIES, Cristina CAMPERO PEREDO, Andrea POSSENTI, Sara LINSE, Tuomas KNOWLES, Christopher DOBSON, Samuel COHEN, Michele VENDRUSCOLO
  • Publication number: 20210145801
    Abstract: A thiazolidinedione or rhodanine compound or a pharmaceutically acceptable salt, tautomer, solvate, hydrate, prodrug, derivative, stereoisomer, analog or isotopically labelled derivative thereof, for use in the treatment and/or prevention of a protein misfolding disease, wherein said compound is not Pioglitazone, Rosiglitazone, Rivoglitazone, Balaglitazone or Mitoglitazone.
    Type: Application
    Filed: April 4, 2019
    Publication date: May 20, 2021
    Inventors: Johnny HABCHI, Xiaoting YANG, Kerry JENKINS, Michele PERNI, Sunehera SARWAT, Joseph MENZIES, Cristina CAMPERO PEREDO, Andrea POSSENTI, Sara LINSE, Tuomas KNOWLES, Christopher DOBSON, Samuel COHEN, Michele VENDRUSCOLO
  • Patent number: D1011111
    Type: Grant
    Filed: July 27, 2023
    Date of Patent: January 16, 2024
    Inventor: Xiaoting Yang
  • Patent number: D1012514
    Type: Grant
    Filed: August 3, 2023
    Date of Patent: January 30, 2024
    Inventor: Xiaoting Yang
  • Patent number: D1019230
    Type: Grant
    Filed: August 9, 2023
    Date of Patent: March 26, 2024
    Inventor: Xiaoting Yang